{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T16:15:24Z","timestamp":1795277724728,"version":"4.10.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007465","name":"UiT The Arctic University of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Reirradiation is a\u00a0potentially useful option for many patients with recurrent cancer, aiming at cure or symptom palliation, depending on disease\/recurrence type and stage. The purpose of this follow-up study to a\u00a0previous review from 2016 was to summarize all recently published randomized trials. Points of interest again included identifcation of methodological strengths and weaknesses, practice-changing results, and open questions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>Systematic review of trials published between 2015 and February 2023.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We reviewed 7\u00a0additional trials, most of which addressed reirradiation of head and neck or brain tumours. The median number of patients was\u00a060. Mirroring the previous review, trial design, primary endpoints and statistical hypotheses varied widely. The updated results only impact on decision making for reirradiation of nasopharynx cancer and glioma. Patients with one of these diseases, as well as other head and neck cancers, may benefit from reirradiation-induced local control, e.g. in terms of progression-free survival. For the first time, hyperfractionated radiotherapy emerged as preferred option for recurrent, inoperable nasopharynx cancer. Despite better therapeutic ratio with hyperfractionation, serious toxicity remains a\u00a0concern after high cumulative total doses. Randomized trials are still lacking for prostate cancer and other sites.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Multicentric randomized trials on reirradiation are feasible and continue to refine the current standard of care for recurrent disease after previous radiotherapy. Ongoing prospective studies such as the European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer (ESTRO-EORTC) observational cohort ReCare (NCT: NCT03818503) will further shape the clinical practice of reirradiation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00066-023-02118-1","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T16:04:31Z","timestamp":1690473871000},"page":"787-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prospective randomized clinical studies involving reirradiation: update of a\u00a0systematic review"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1592-2908","authenticated-orcid":false,"given":"Carsten","family":"Nieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Willmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus H.","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"2118_CR1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00066-023-02043-3","volume":"199","author":"S Cozzi","year":"2023","unstructured":"Cozzi\u00a0S, Finocchi Ghersi\u00a0S, Bardoscia\u00a0L et al (2023) Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes. Strahlenther Onkol 199:554\u2013564","journal-title":"Strahlenther Onkol"},{"key":"2118_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00066-021-01748-7","volume":"197","author":"A Pontoriero","year":"2021","unstructured":"Pontoriero\u00a0A, Lillo\u00a0S, Caravatta\u00a0L et al (2021) Cumulative dose, toxicity, and outcomes of spinal metastases re-irradiation: Systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Strahlenther Onkol 197:369\u2013384","journal-title":"Strahlenther Onkol"},{"key":"2118_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00066-020-01647-3","volume":"197","author":"J Boustani","year":"2021","unstructured":"Boustani\u00a0J, Ruffier\u00a0A, Moya-Plana\u00a0A et al (2021) Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a\u00a0non-endemic area. Strahlenther Onkol 197:188\u2013197","journal-title":"Strahlenther Onkol"},{"key":"2118_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00066-020-01585-0","volume":"196","author":"A Baehr","year":"2020","unstructured":"Baehr\u00a0A, Trog\u00a0D, Oertel\u00a0M et al (2020) Re-irradiation for recurrent glioblastoma multiforme: a\u00a0critical comparison of different concepts. Strahlenther Onkol 196:457\u2013464","journal-title":"Strahlenther Onkol"},{"key":"2118_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00066-020-01577-0","volume":"196","author":"C Nieder","year":"2020","unstructured":"Nieder\u00a0C, Manns\u00e5ker\u00a0B, Yobuta\u00a0R et al (2020) Provider decision regret\u2011a useful method for analysis of palliative thoracic re-irradiation for lung cancer? Strahlenther Onkol 196:315\u2013324","journal-title":"Strahlenther Onkol"},{"key":"2118_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00066-019-01457-2","volume":"195","author":"I Schlampp","year":"2019","unstructured":"Schlampp\u00a0I, Rieber\u00a0J, Adeberg\u00a0S et al (2019) Re-irradiation in locally recurrent lung cancer patients. Strahlenther Onkol 195:725\u2013733","journal-title":"Strahlenther Onkol"},{"key":"2118_CR7","first-page":"152","volume":"3","author":"C Nieder","year":"2013","unstructured":"Nieder\u00a0C, Andratschke\u00a0NH, Grosu\u00a0AL (2013) Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles. Am J Cancer Res 3:152\u2013158","journal-title":"Am J Cancer Res"},{"key":"2118_CR8","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","volume":"23","author":"N Andratschke","year":"2022","unstructured":"Andratschke\u00a0N, Willmann\u00a0J, Appelt\u00a0AL et al (2022) European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol 23:e469\u2013e478 (Erratum in: Lancet Oncol 2022;23:e492)","journal-title":"Lancet Oncol"},{"key":"2118_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.clon.2006.02.003","volume":"18","author":"JC Li","year":"2006","unstructured":"Li\u00a0JC, Hu\u00a0CS, Jiang\u00a0GL et al (2006) Dose escalation of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma: a\u00a0prospective randomised study. Clin Oncol (R Coll Radiol) 18:293\u2013299","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2118_CR10","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1002\/cncr.28934","volume":"120","author":"YM Tian","year":"2014","unstructured":"Tian\u00a0YM, Zhao\u00a0C, Guo\u00a0Y et al (2014) Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A phase 2, single-center, randomized controlled trial. Cancer 120:3502\u20133509","journal-title":"Cancer"},{"key":"2118_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40880-016-0081-7","volume":"35","author":"Y Guan","year":"2016","unstructured":"Guan\u00a0Y, Liu\u00a0S, Wang\u00a0HY, Guo\u00a0Y et al (2016) Long-term outcomes of a\u00a0phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma. Chin J Cancer 35:20","journal-title":"Chin J Cancer"},{"key":"2118_CR12","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1200\/JCO.2007.15.0102","volume":"26","author":"F Janot","year":"2008","unstructured":"Janot\u00a0F, de Raucourt\u00a0D, Benhamou\u00a0E et\u00a0al (2008) Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J\u00a0Clin Oncol 26:5518\u20135523","journal-title":"J Clin Oncol"},{"key":"2118_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.radonc.2011.06.025","volume":"100","author":"J Tortochaux","year":"2011","unstructured":"Tortochaux\u00a0J, Tao\u00a0Y, Tournay\u00a0E et al (2011) Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a\u00a0second primary head and neck squamous cell carcinoma, treated with a\u00a0palliative intent. Radiother Oncol 100:70\u201375","journal-title":"Radiother Oncol"},{"key":"2118_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.medici.2014.06.006","volume":"50","author":"V Rud\u017eianskas","year":"2014","unstructured":"Rud\u017eianskas\u00a0V, In\u010di\u016bra\u00a0A, Vaitkus\u00a0S et al (2014) Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a\u00a0single-institution comparative study. Medicina (Kaunas) 50:92\u201399","journal-title":"Medicina (Kaunas)"},{"key":"2118_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1470-2045(13)70556-4","volume":"15","author":"E Chow","year":"2014","unstructured":"Chow\u00a0E, van der Linden\u00a0YM, Roos\u00a0D et\u00a0al (2014) A randomized trial of single and multiple fractions of repeat radiation for painful bone metastases. Lancet Oncol 15:164\u2013171","journal-title":"Lancet Oncol"},{"key":"2118_CR16","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1158\/1078-0432.CCR-14-0951-T","volume":"20","author":"W Wick","year":"2014","unstructured":"Wick\u00a0W, Fricke\u00a0H, Junge\u00a0K et\u00a0al (2014) A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma. Clin Cancer Res 20:6304\u20136313","journal-title":"Clin Cancer Res"},{"key":"2118_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0304-3835(02)00742-5","volume":"193","author":"VE Kouloulias","year":"2003","unstructured":"Kouloulias\u00a0VE, Plataniotis\u00a0GA, Kouvaris\u00a0JR et al (2003) Re-irradiation in conjunction with liposomal doxorubicin for the treatment of skin metastases of recurrent breast cancer: a\u00a0radiobiological approach and 2\u00a0year of follow-up. Cancer Lett 193:33\u201340","journal-title":"Cancer Lett"},{"key":"2118_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00066-016-1024-6","volume":"192","author":"C Nieder","year":"2016","unstructured":"Nieder\u00a0C, Langendijk\u00a0JA, Guckenberger\u00a0M et\u00a0al (2016) Prospective randomized clinical studies involving reirradiation: Lessons learned. Strahlenther Onkol 192:679\u2013686","journal-title":"Strahlenther Onkol"},{"key":"2118_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1470-2045(20)30673-2","volume":"22","author":"YP Liu","year":"2021","unstructured":"Liu\u00a0YP, Wen\u00a0YH, Tang\u00a0J et al (2021) Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a\u00a0multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol 22:381\u2013390","journal-title":"Lancet Oncol"},{"issue":"10380","key":"2118_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0140-6736(23)00269-6","volume":"401","author":"R You","year":"2023","unstructured":"You\u00a0R, Liu\u00a0YP, Xie\u00a0YL et al (2023) Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a\u00a0multicentre, randomised, open-label, phase 3 trial. Lancet 401(10380):917\u2013927","journal-title":"Lancet"},{"key":"2118_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.radonc.2018.05.005","volume":"128","author":"Y Tao","year":"2018","unstructured":"Tao\u00a0Y, Faivre\u00a0L, Laprie\u00a0A et al (2018) Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab. Radiother Oncol 128:467\u2013471","journal-title":"Radiother Oncol"},{"key":"2118_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11060-020-03526-4","volume":"148","author":"D Bergman","year":"2020","unstructured":"Bergman\u00a0D, Modh\u00a0A, Schultz\u00a0L et al (2020) Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma. J\u00a0Neurooncol 148:353\u2013361","journal-title":"J Neurooncol"},{"key":"2118_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ijrobp.2020.06.021","volume":"108","author":"M Voss","year":"2020","unstructured":"Voss\u00a0M, Wagner\u00a0M, von Mettenheim\u00a0N et al (2020) ERGO2: A prospective, randomized trial of calorie-restricted ketogenic diet and fasting in addition to reirradiation for malignant glioma. Int J Radiat Oncol Biol Phys 108:987\u2013995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2118_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1200\/JCO.22.00164","volume":"41","author":"CI Tsien","year":"2023","unstructured":"Tsien\u00a0CI, Pugh\u00a0SL, Dicker\u00a0AP et\u00a0al (2023) NRG Oncology\/RTOG1205: A randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma. J\u00a0Clin Oncol 41:1285\u20131295","journal-title":"J Clin Oncol"},{"key":"2118_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/0284186X.2022.2033315","volume":"61","author":"D Schouten","year":"2022","unstructured":"Schouten\u00a0D, van Os\u00a0R, Westermann\u00a0AM et al (2022) A randomized phase-II study of reirradiation and hyperthermia versus reirradiation and hyperthermia plus chemotherapy for locally recurrent breast cancer in previously irradiated area. Acta Oncol 61:441\u2013448","journal-title":"Acta Oncol"},{"key":"2118_CR26","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0360-3016(01)01745-X","volume":"51","author":"SA Spencer","year":"2001","unstructured":"Spencer\u00a0SA, Harris\u00a0J, Wheeler\u00a0RH et al (2001) RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5\u2011fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51:1299\u20131304","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2118_CR27","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","volume":"25","author":"CJ Langer","year":"2007","unstructured":"Langer\u00a0CJ, Harris\u00a0J, Horwitz\u00a0EM et al (2007) Phase\u00a0II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group protocol 9911. J\u00a0Clin Oncol 25:4800\u20134805","journal-title":"J Clin Oncol"},{"key":"2118_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.adro.2017.02.005","volume":"2","author":"C Nieder","year":"2017","unstructured":"Nieder\u00a0C, Langendijk\u00a0JA, Guckenberger\u00a0M et\u00a0al (2017) Preserving the legacy of reirradiation: A narrative review of historical publications. Adv Radiat Oncol 2:176\u2013182","journal-title":"Adv Radiat Oncol"},{"key":"2118_CR29","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ijrobp.2021.01.041","volume":"110","author":"WT Ng","year":"2021","unstructured":"Ng\u00a0WT, Soong\u00a0YL, Ahn\u00a0YC et\u00a0al (2021) International recommendations on reirradiation by intensity modulated radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 110:682\u2013695","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2118_CR30","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict\u00a0SH, Yenice\u00a0KM, Followill\u00a0D et\u00a0al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37:4078\u20134101","journal-title":"Med Phys"},{"key":"2118_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11060-021-03857-w","volume":"158","author":"M Ziu","year":"2022","unstructured":"Ziu\u00a0M, Goyal\u00a0S, Olson\u00a0JJ (2022) Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults. J\u00a0Neurooncol 158:255\u2013264","journal-title":"J Neurooncol"},{"key":"2118_CR32","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ijrobp.2015.12.361","volume":"94","author":"NR Datta","year":"2016","unstructured":"Datta\u00a0NR, Puric\u00a0E, Klingbiel\u00a0D et al (2016) Hyperthermia and radiation therapy in locoregional recurrent breast cancers: A systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 94:1073\u20131087","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2118_CR33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/0360-3016(95)02137-X","volume":"34","author":"B Emami","year":"1996","unstructured":"Emami\u00a0B, Scott\u00a0C, Perez\u00a0CA et\u00a0al (1996) Phase\u00a0III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 34:1097\u20131104","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2118_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4048\/jbc.2021.24.e27","volume":"24","author":"M Bottero","year":"2021","unstructured":"Bottero\u00a0M, Borzillo\u00a0V, Pergolizzi\u00a0S et\u00a0al (2021) The Italian Association of Radiotherapy and Oncology recommendation for breast tumor recurrence: grades of recommendation, assessment, development and evaluation criteria. J\u00a0Breast Cancer 24:241\u2013252","journal-title":"J Breast Cancer"},{"key":"2118_CR35","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.ctrv.2021.102206","volume":"98","author":"BA Jereczek-Fossa","year":"2021","unstructured":"Jereczek-Fossa\u00a0BA, Marvaso\u00a0G, Zaffaroni\u00a0M et al (2021) Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus. Cancer Treat Rev 98:102206 (on the behalf of the European Society for Radiotherapy, Oncology Advisory Committee on Radiation Oncology Practice (ESTRO ACROP))","journal-title":"Cancer Treat Rev"},{"key":"2118_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00066-015-0939-7","volume":"192","author":"W Harms","year":"2016","unstructured":"Harms\u00a0W, Budach\u00a0W, Dunst\u00a0J et\u00a0al (2016) Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Strahlenther Onkol 192:199\u2013208","journal-title":"Strahlenther Onkol"},{"key":"2118_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2023.05.007","author":"A Embring","year":"2023","unstructured":"Embring\u00a0A, Blomstrand\u00a0M, Asklid\u00a0A et al (2023) Re-irradiation in paediatric tumours of the central nervous system: National guidelines from the Swedish workgroup of paediatric radiotherapy. Clin Oncol (r Coll Radiol). https:\/\/doi.org\/10.1016\/j.clon.2023.05.007","journal-title":"Clin Oncol (r Coll Radiol)"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02118-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02118-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02118-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T17:06:02Z","timestamp":1692896762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02118-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2118"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02118-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"13 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.\u00a0Nieder, J.\u00a0Willmann and N.H.\u00a0Andratschke declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}